Download FREE Report Sample
Download Free sampleGastroesophageal Reflux Disease Drugs and Devices Market contains market size and forecasts of Gastroesophageal Reflux Disease (GERD) Drugs and Devices in Global, including the following market information:
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market was valued at 4940.8 million in 2021 and is projected to reach US$ 4440.9 million by 2028, at a CAGR of -1.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastroesophageal Reflux Disease (GERD) Drugs and Devices include AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited, Rottapharm (Meda AB), Pfizer, Inc., Eisai Co. Ltd., The Procter & Gamble Company, Mederi Therapeutics and Aros Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastroesophageal Reflux Disease (GERD) Drugs and Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, by Type, 2021 (%)
Medication
Minimally Invasive Surgery
Invasive Surgery
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, by Application, 2021 (%)
Heartburn
Acid reflux disorders
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroesophageal Reflux Disease (GERD) Drugs and Devices revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gastroesophageal Reflux Disease (GERD) Drugs and Devices revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca, Plc.
Addex Therapeutics
Takeda Pharmaceutical Company Limited
Rottapharm (Meda AB)
Pfizer, Inc.
Eisai Co. Ltd.
The Procter & Gamble Company
Mederi Therapeutics
Aros Pharma
Torax Medical, Inc.
BD
EndoGastric Solutions
Medigus Ltd.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
